Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2021-12-01 00:00:00 ET · period of report 2021-11-30 · accession 0001562180-21-007369 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-01 | 2021-11-30 | EWTX | CSO, Dir | M - OptEx | $0.2191 | +172.6K | 172.6K | New | +$37.8K | |
| DM | 2021-12-01 | 2021-11-30 | EWTX | CSO, Dir | M - OptEx | $0.00 | -172.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-30 | M | A | 147,585 | $0.18 | 147,585 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-30 | M | A | 25,000 | $0.45 | 172,585 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-11-30 | M | D | 25,000 | $0.00 | 130,352 | D | $0.45 · — to 2028-08-30 | 25,000 Common Stock | (F2) 1/48th of the shares subject to the option vested on September 10, 2018 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date. |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-11-30 | M | D | 147,585 | $0.00 | 0 | D | $0.18 · — to 2027-08-08 | 147,585 Common Stock | (F1) 1/4th of the shares subject to the option vested on July 27, 2018 and 1/48th of the shares subject to the option vested each month thereafter. |